Subtypes of ischemic cerebral circulation disorders at young age: diagnosis and treatment
https://doi.org/10.14412/2074-2711-2012-418
Abstract
The paper shows that it is urgent to study stroke in young patients aged 15—45 years. In accordance with the TOAST classification, the author presents the major pathogenetic subtypes of ischemic stroke (IS): atherothromboembolic, cardioembolic, lacunar, that of other known and unknown etiology. The clinical picture and diagnostic principles of IS at young age are considered. Particular emphasis is laid on therapy for IS. It is pointed out that the leading therapy option in these patients is thrombolysis; intravenous recombinant tissue plasminogen activator is more frequently used; oral anticoagulants and antiplatelet agents are certain to prescribe.
About the Author
Natalia Vyacheslavovna PizovaDepartment of Nervous System Diseases and Medical Genetics with Neurosurgery
References
1. <div><p>Haapaniemi H., Hillbom M., Juvela S. Lifestyle-associated risk factors for acute brain infarction among persons of working age. Stroke 1997;28:26-30.</p><p>Kittner S.J., McCarter R.J., Sherwin R.W. et al. Black-white differences in stroke risk among young adults. Stroke 1993;24(1):I13—5.</p><p>Adams H.P., Bendixen B.H., Kappelle J. et al. Classification of subtype of acute ischemic stroke. Stroke 1993:24;35—41.</p><p>Kittner S.J., Stern B.J., Wozniak M. et al. Cerebral infarction in young adults: the Baltimore-Washington Cooperative Young Stroke Study. Neurology 1998;50:890-4.</p><p>Lee T.H., Hsu W.C., Chen C.J. et al. Etiologic study of young ischemic stroke in Taiwan. Stroke 2002;33:1950-5.</p><p>Nedeltchev K., der Maur T.A., Georgiadis D. et al. Ischaemic stroke in young adults: predictors of outcome and recurrence. J Neurol Neurosurg Psychiatry 2005;76:191-5.</p><p>Adams H.PJr., Kappelle L.J., Biller J. et al. Ischemic stroke in young adults: experience in 329 patients enrolled in the Iowa Registry of stroke in young adults. Arch Neurol 1995;52:491-5.</p><p>Kwon S.U., Kim J.S., Lee J.H. et al. Ischemic stroke in Korean young adults. Acta Neurol Scand 2000;101:19-24.</p><p>Varona J.F., Guerra J.M., Bermejo F. et al. Causes of ischemic stroke in young adults, and evolution of the etiological diagnosis over the long term. Eur Neurol 2007;57(4):212-8.</p><p>Yonemura K., Kimura K., Hasegawa Y. et al. Analysis of ischemic stroke in patients aged up to 50 years. Rinsho Shinkeigaku 2000;40(9):881-6.</p><p>Cerrato P., Grasso M., Imperiale D. et al. Stroke in young patients: etiopathogenesis and risk factors in different age classes. Cerebrovasc Dis 2004;18(2):154-9.</p><p>Putaala J., Metso A.J., Metso T.M. et al. Analysis of 1008 Consecutive Patients Aged 15 to 49 With First-Ever Ischemic Stroke. The Helsinki Young Stroke Registry. Stroke 2009;40:1195-203.</p><p>De Bray J.M., Penisson-Besnier I., Dubas F. et al. Extracranial and intracranial vertebrobasilar dissections: diagnosis and prognosis. J Neurol Neurosurg Psychiatry 1997;63:46-51.</p><p>Суслина З.А., Верещагин Н.В., Пирадов М.А. Подтипы ишемического нарушения мозгового кровообращения: диагностика и лечение. Cons Med 2001;3(5):218—21.</p><p>Суслина З.А., Танашян М.М. Антитромботическая терапия в ангионеврологии. М.: Медицинская книга, 2004;110 с.</p><p>Barnett H.J.M. Stroke by cause: some common, some exotic, some controversial. Stroke 2005;36:2523-5.</p><p>McCabe D.J.H., Rakhit R.D. Antithrombotic and interventional treatment options in cardioembolic transient ischaemic attack and ischaemic stroke. J Neurol Neurosurg Psychiatry 2007;78:14-24.</p><p>The European Stroke Organization (ESO) Executive Committee and the ESO Writing Committee: Guidelines for management of ischaemic stroke and transient ischaemic attacks 2008. Cerebrovasc Dis 2008;25:457-507.</p><p>Alberts M.J. Antithrombotic Trialists’ Collaboration. Collaborative metaanalysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J 2002;324:71-86.</p><p>Fuster V., Ryden L.E., Asinger R.W. et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. Eur Heart J 2001;22(20):1852—923.</p><p>Hart R.G., Pearce L.A., McBride R. et al. Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators. Stroke 1999;30(6):1223-9.</p><p>Сергеев Д.В., Пирадов М.А., Максимова М.Ю. и др. Новые возможности нейропротекции при ишемическом инсульте. Неврол нейропсихиатр психосом 2011;4:56-63.</p><p>Saver J.L., Wilterdink J. Choline precursors in acute and subacute human stroke: a metaanalysis. Stroke 2002;33:353.</p><p>Нордвик Б. Механизм действия и клиническое применение препарата актовегин. В сб.: Актовегин. Новые аспекты клинического применения. М., 2002;18—24.</p><p>Румянцева С.А. Фармакологические характеристики и механизм действия актовегина. В сб.: Актовегин. Новые аспекты клинического применения. М., 2002;3—9.</p><p>Скоромец А.А., Ковальчук В.В. Анализ эффективности различных лекарственных препаратов в лечении инсультов. В сб.: Актовегин в неврологии. М., 2002;152—64.</p><p>Федин А.И., Румянцева С.А. Антиоксидантная терапия нарушений мозгового кровообращения. Леч нервн бол 2001;2:7-12.</p><p>Федин А.И., Румянцева С.А. Принципы антигипоксической терапии у больных с инсультом. Интенсивная терапия ишемического инсульта. Рук-во для врачей. М.: Медицинская книга, 2004;160—251.</p></div><br />
Review
For citations:
Pizova N.V. Subtypes of ischemic cerebral circulation disorders at young age: diagnosis and treatment. Neurology, Neuropsychiatry, Psychosomatics. 2012;4(4):34-38. (In Russ.) https://doi.org/10.14412/2074-2711-2012-418
Views: 1620
Email this article 